These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4427327)

  • 1. Study of pituitary hormone analogs for their inhibitory properties and resistance to carboxamidopeptidases: (9-L-proline)oxytocin, (9-L-glutamic acid)oxytocin, and (8-L-lysine,9-glycine methylamide)oxytocin.
    Grzonka Z; Glass JD; Schwartz IL; Walter R
    J Med Chem; 1974 Dec; 17(12):1294-8. PubMed ID: 4427327
    [No Abstract]   [Full Text] [Related]  

  • 2. (1-beta-mercapto-beta,beta-diethylpropionic acid,4-leucine)-8-lysine-vasopressin and (1-beta-mercapto-beta,beta-diethylpropionic acid,4-leucine)oxytocin, compounds possessing antihormonal properties.
    Dyckes DF; Nestor JJ; Ferger MF; Du Vigneaud V; Chan WY
    J Med Chem; 1974 Sep; 17(9):969-72. PubMed ID: 4855467
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthetic metabolites of neurohypophyseal hormones. (Des-9-glycinamide)oxytocin and (des-9-glycinamide, des-8-leucine)oxytocin.
    Walter R; Havran RT; Schwartz IL
    J Med Chem; 1976 Feb; 19(2):328-30. PubMed ID: 1249815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and some of the pharmacological properties of (4-leucine)-8-lysine-vasopressin and (1-deamino,4-leucine)-8-lysine-vasopressin.
    Dyckes DF; Ferger MF; Du Vigneaud V; Chan WY
    J Med Chem; 1973 Jul; 16(7):843-7. PubMed ID: 4725931
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological effects of introducing a double bond into a binding site of oxytocin. Analogues with L-3,4-dehydroproline in position 7.
    Moore S; Felix AM; Meienhofer J; Smith CW; Walter R
    J Med Chem; 1977 Apr; 20(4):495-500. PubMed ID: 850234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined high oxytocic with negligible antidiuretic and pressor activities in multisubstituted oxytocins.
    Stahl GL; Walter R
    J Med Chem; 1977 Apr; 20(4):492-5. PubMed ID: 850233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and some pharmacological properties of (1-deamino,9-thioglycine)oxytocin.
    Jones WC; Nestor JJ; Du Vigneaud V
    J Am Chem Soc; 1973 Aug; 95(17):5677-9. PubMed ID: 4733810
    [No Abstract]   [Full Text] [Related]  

  • 8. Oxytocin analogues with combined high smooth muscle and negligible antidiuretic activities. Investigation of position 7 in neurohypophyseal hormones.
    Walter R; Smith CW; Roy J; Formento A
    J Med Chem; 1976 Jun; 19(6):822-5. PubMed ID: 985884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamine isomers of oxytocin and deamino-oxytocin: synthesis and pharmacological properties of [4-N4-methyl-L-asparagine]-oxytocin and [1-beta-mercaptopropionic acid, 4-N4-methyl-L-asparagine]-oxytocin.
    Havran RT; Schwartz IL; Walter R
    Mol Pharmacol; 1969 Jan; 5(1):83-9. PubMed ID: 5373890
    [No Abstract]   [Full Text] [Related]  

  • 10. [1-Beta-mercapto-beta,beta-pentamethylenepropionic acid]oxytocin, a potent inhibitor of oxytocin.
    Nestor JJ; Ferger MF; du Vigneaud V
    J Med Chem; 1975 Mar; 18(3):284-7. PubMed ID: 1133819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and some pharmacological properties of 8-L-methionine-oxytocin.
    Bodanszky M; Chandramouli N; Martinez J; Walter R
    J Med Chem; 1979 Mar; 22(3):270-3. PubMed ID: 423209
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of an amide group in place of the disulfide bridge in deamino-oxytocin.
    Hase S; Sakakibara S; Wahrenburg M; Walter R
    J Med Chem; 1972 Oct; 15(10):1017-9. PubMed ID: 4672192
    [No Abstract]   [Full Text] [Related]  

  • 13. Hydroxy analogues of oxytocin and of lysine-vasopressin.
    Bisset GW; Chowdrey HS; Hope DB; Nilwises N; Wälti M
    Br J Pharmacol; 1979 Dec; 67(4):575-85. PubMed ID: 519108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystalline deamino-dicarba-oxytocin. Preparation and some pharmacological properties.
    Yamanaka T; Hase S; Sakakibara S; Schwartz IL; Dubois BM; Walter R
    Mol Pharmacol; 1970 Sep; 6(5):474-80. PubMed ID: 5466703
    [No Abstract]   [Full Text] [Related]  

  • 15. Further studies of the role of the asparagine residue in oxytocin. Synthesis and biological properties of (5- , -diaminobutyric acid)oxytocin.
    Hase S; Schwartz IL; Walter R
    J Med Chem; 1972 Feb; 15(2):126-8. PubMed ID: 5008236
    [No Abstract]   [Full Text] [Related]  

  • 16. [Synthesis and some pharmacological activities of [2-L-valine]-oxytocin and [2-L-leucine]-oxytocin.
    Hruby VJ; Du Vigneaud V
    J Med Chem; 1969 Sep; 12(5):731-3. PubMed ID: 5818088
    [No Abstract]   [Full Text] [Related]  

  • 17. The synthesis and some pharmacological activities of[4-L-norvaline]-oxytocin and [4-L-norleucine]-oxytocin and their deamino analogs.
    Flouret G; Du Vigneaud V
    J Med Chem; 1969 Nov; 12(6):1035-8. PubMed ID: 5389145
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis of three oxytocin analogs related to (1-deaminopenicillamine)oxytocin possessing antioxytocic acitvity.
    Vavrek RJ; Ferger MF; Allen GA; Rich DH; Blomquist AT; Du Vigneaud V
    J Med Chem; 1972 Feb; 15(2):123-6. PubMed ID: 5008235
    [No Abstract]   [Full Text] [Related]  

  • 19. Biologically active macromolecular forms of oxytocin. [8-Lysine]oxytocin as a suitable ligand.
    Snell CR; Smyth DG
    Biochem J; 1977 Jul; 165(1):43-7. PubMed ID: 889573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and certain pharmacological properties of lysine-vasopressinoic acid methylamide and lysine-vasopressinoic acid dimethylamide.
    Glass JD; du Vigneaud V
    J Med Chem; 1972 May; 15(5):486-8. PubMed ID: 5064318
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.